{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T06:56:11Z","timestamp":1792133771587,"version":"4.4.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,2,4]],"date-time":"2020-02-04T00:00:00Z","timestamp":1580774400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["arthroplastytoday.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Arthroplasty Today"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.artd.2020.02.001","type":"journal-article","created":{"date-parts":[[2020,3,7]],"date-time":"2020-03-07T08:04:38Z","timestamp":1583568278000},"page":"220-223","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Clinical outcome evaluation of intraosseous vancomycin in total knee arthroplasty"],"prefix":"10.1016","volume":"6","author":[{"given":"Katharine D.","family":"Harper","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley S.","family":"Lambert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"O\u2019Dowd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Incavo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.artd.2020.02.001_bib1","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/aas.12454","article-title":"Intraosseous and intravenous administration of antibiotics yields comparable plasma concentrations during experimental septic shock","volume":"59","author":"Strandberg","year":"2015","journal-title":"Acta Anaesthesiol Scand"},{"issue":"8","key":"10.1016\/j.artd.2020.02.001_bib2","first-page":"946","article-title":"Evaluation of intraosseous vs intravenous antibiotic levels in a porcine model","volume":"145","author":"Jaimovich","year":"1991","journal-title":"Am J Dis Child"},{"issue":"1","key":"10.1016\/j.artd.2020.02.001_bib3","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s11999-013-3038-z","article-title":"Higher tissue concentrations of vancomycin with low-dose intraosseous regional versus systemic prophylaxis in TKA: a randomized trial","volume":"472","author":"Young","year":"2014","journal-title":"Clin Orthop Relat Res"},{"issue":"7S","key":"10.1016\/j.artd.2020.02.001_bib4","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/j.arth.2018.03.013","article-title":"Intraosseous regional prophylaxis provides higher tissue concentrations in high BMI patients in total knee arthroplasty: a randomized trial","volume":"33","author":"Chin","year":"2018","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.artd.2020.02.001_bib5","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s11999.0000000000000013","article-title":"Higher tissue concentrations of vancomycin achieved with intraosseus regional prophylaxis in revision TKA: a randomized controlled trial","volume":"476","author":"Young","year":"2018","journal-title":"Clin Orthop Relat Res"},{"issue":"2","key":"10.1016\/j.artd.2020.02.001_bib6","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/cc1871","article-title":"Red man syndrome","volume":"7","author":"Sivagnanam","year":"2003","journal-title":"Crit Care"},{"key":"10.1016\/j.artd.2020.02.001_bib7","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0924-8579(98)00025-9","article-title":"Comparative safety of teicoplanin and vancomycin","volume":"10","author":"Wilson","year":"1998","journal-title":"Int J Antimicrob Agents"},{"issue":"29","key":"10.1016\/j.artd.2020.02.001_bib8","doi-asserted-by":"crossref","first-page":"e6903","DOI":"10.1097\/MD.0000000000006903","article-title":"Timing of preoperative antibiotic prophylaxis in 54,552 patients and the risk of surgical site infection: a systematic review and meta-analysis","volume":"96","author":"Willem de Jonge","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.artd.2020.02.001_bib9","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.jtcvs.2012.01.087","article-title":"When the timing is right: antibiotic timing and infection after cardiac surgery","volume":"144","author":"Koch","year":"2012","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.artd.2020.02.001_bib10","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1093\/jac\/dkl279","article-title":"Timing of vancomycin prophylaxis for cardiac surgery patients and the risk of surgical site infections","volume":"58","author":"Garey","year":"2006","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"7","key":"10.1016\/j.artd.2020.02.001_bib11","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1086\/512192","article-title":"Antibiotic prophylaxis and the risk of surgical site infections following total hip arthroplasty: timely administration is the most important factor","volume":"44","author":"Van Kasteren","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.artd.2020.02.001_bib12","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.wneu.2014.12.033","article-title":"The use of vancomycin powder in modern spine surgery: systematic review and meta-analysis of the clinical evidence","volume":"83","author":"Bakhsheshian","year":"2015","journal-title":"World Neurosurg"},{"issue":"4","key":"10.1016\/j.artd.2020.02.001_bib13","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/BRS.0000000000001710","article-title":"Is intraoperative local vancomycin powder the answer to surgical site infections in spine surgery?","volume":"42","author":"Hey","year":"2017","journal-title":"Spine (Phila Pa 1976)"},{"issue":"4","key":"10.1016\/j.artd.2020.02.001_bib14","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.artd.2018.07.011","article-title":"Intrawound vancomycin in primary hip and knee arthroplasty: a safe and cost-effective means to decrease early periprosthetic joint infection","volume":"4","author":"Patel","year":"2018","journal-title":"Arthroplast Today"},{"issue":"4 Suppl","key":"10.1016\/j.artd.2020.02.001_bib15","first-page":"53","article-title":"No change in infection rates with inraoperative vancomycin powder in total joint arthroplasty","volume":"100-B","author":"Lum","year":"2018","journal-title":"Orthopaedic Proc"},{"issue":"7","key":"10.1016\/j.artd.2020.02.001_bib16","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.arth.2014.02.012","article-title":"Establishing a role for vancomycin powder application for prosthetic joint infection prevention\u2014results of a wear simulation study","volume":"29","author":"Qadir","year":"2014","journal-title":"J\u00a0Arthroplasty"},{"issue":"3","key":"10.1016\/j.artd.2020.02.001_bib17","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.arth.2015.10.015","article-title":"Serum and wound vancomycin levels after intrawound administration in primary total joint arthroplasty","volume":"32","author":"Johnson","year":"2017","journal-title":"J\u00a0Arthroplasty"},{"issue":"4","key":"10.1016\/j.artd.2020.02.001_bib18","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1308\/rcsann.2016.0324","article-title":"Acute kidney injury following primary hip and knee arthroplasty surgery","volume":"99","author":"Ferguson","year":"2017","journal-title":"Ann R Coll Surg Engl"},{"issue":"21","key":"10.1016\/j.artd.2020.02.001_bib19","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.2106\/JBJS.16.01027","article-title":"The rate of acute kidney injury after total hip arthroplasty is low but increases significantly in patients with specific comorbidities","volume":"99","author":"Gharaibeh","year":"2017","journal-title":"J\u00a0Bone Joint Surg Am"},{"issue":"4","key":"10.1016\/j.artd.2020.02.001_bib20","doi-asserted-by":"crossref","first-page":"ofz141","DOI":"10.1093\/ofid\/ofz141","article-title":"Acute tubular necrosis associated with high serum vancomycin and tobramycin levels after revision of total knee arthroplasty with antibiotic-containing calcium sulfate beads","volume":"6","author":"Ma","year":"2019","journal-title":"Open Forum Infect Dis"},{"issue":"7","key":"10.1016\/j.artd.2020.02.001_bib21","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1007\/s11999-014-4062-3","article-title":"Addition of vancomycin to cefazolin prophylaxis is associated with acute kidney injury after primary joint arthroplasty","volume":"473","author":"Courtney","year":"2015","journal-title":"Clin Orthop Relat Res"},{"issue":"1","key":"10.1016\/j.artd.2020.02.001_bib22","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s11999-012-2489-y","article-title":"Complications of total knee arthroplasty: standardized list and definitions of the Knee Society","volume":"471","author":"Healy","year":"2013","journal-title":"Clin Orthop Relat Res"},{"issue":"4","key":"10.1016\/j.artd.2020.02.001_bib23","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3928\/01477447-20170208-06","article-title":"Use of articulating spacer technique in revision total knee arthroplasty complicated by sepsis: a systematic meta-analysis","volume":"40","author":"Spivey","year":"2017","journal-title":"Orthopedics"}],"container-title":["Arthroplasty Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352344120300145?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352344120300145?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T18:07:01Z","timestamp":1762452421000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352344120300145"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S2352344120300145"],"URL":"https:\/\/doi.org\/10.1016\/j.artd.2020.02.001","relation":{},"ISSN":["2352-3441"],"issn-type":[{"value":"2352-3441","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical outcome evaluation of intraosseous vancomycin in total knee arthroplasty","name":"articletitle","label":"Article Title"},{"value":"Arthroplasty Today","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.artd.2020.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Inc. on behalf of The American Association of Hip and Knee Surgeons.","name":"copyright","label":"Copyright"}]}}